Bioventus taps former Stryker, Smith+Nephew executive as new CEO

Written by Alan Condon | March 25, 2020 | Print  |

The board of managers at Bioventus unanimously appointed Ken Reali to succeed Tony Bihl as CEO when he retires April 20.

Mr. Reali has more than 28 years of experience in the medical device industry, including executive roles at Stryker, Smith+Nephew and Baxano Surgical.

Since 2015, he has operated as president and CEO of medical device company Clinical Innovations.

Beginning his career at Biomet, Mr. Reali progressed to marketing director and vice president at Stryker, senior vice president and general manager at Smith+Nephew and president and CEO of spinal device company Baxano Surgical.

He is on the boards of Ossio Integrative Orthopedics, AdvaMed and AdvaMed Accel and also serves as chairman of the ethics and compliance committee for AdvaMed. 

More articles on devices:
NuVasive recalls Magec system for scoliosis, advises surgeons to perform clinical follow-ups
Zimmer Biomet asks European hospitals to remove orthopedic spacer molds
Resurgens Orthopaedics postpones elective surgeries, remains open for urgent care

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers